Ader DN. Developing the patient-reported outcomes measurement information system (PROMIS). Med Care. 2007;45(5):S1–2. https://doi.org/10.1097/01.mlr.0000260537.45076.74.

Article  Google Scholar 

American Cancer Society. Cancer Facts & Figures 2022. Atlanta: American Cancer Society; 2022. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2022/2022-cancer-facts-and-figures.pdf

Ardeshirrouhanifard S, Fossa SD, Huddart R, Monahan PO, Fung C, Song Y, Dolan ME, Feldman DR, Hamilton RJ, Vaughn D, Martin NE, Kollmannsberger C, Dinh P, Einhorn L, Frisina RD, Travis LB. Ototoxicity after cisplatin-based chemotherapy: factors associated with discrepancies between patient-reported outcomes and audiometric assessments. Ear Hear. 2022. https://doi.org/10.1097/AUD.0000000000001172.

Article  Google Scholar 

Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TA, Tervonen H, Thursfield V, Ransom D, Shack L, Woods RR, Turner D, Leonfellner S, Ryan S, Saint-Jacques N, De P, McClure C, Ramanakumar AV, Stuart-Panko H, . . . Bray F. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11), 1493-1505. https://doi.org/10.1016/S1470-2045(19)30456-5

Arnold ML, Hyer K, Chisolm T. Medicaid hearing aid coverage for older adult beneficiaries: a state-by-state comparison. Health Aff (Millwood). 2017;36(8):1476–84. https://doi.org/10.1377/hlthaff.2016.1610.

Article  Google Scholar 

Arora R, Thakur JS, Azad RK, Mohindroo NK, Sharma DR, Seam RK. Cisplatin-based chemotherapy: add high-frequency audiometry in the regimen. Indian J Cancer. 2009;46(4):311–7. https://doi.org/10.4103/0019-509X.55551.

Article  CAS  Google Scholar 

ASCO, A. S. o. C. O. Long-term side effects of cancer treatment. 2019. https://www.cancer.net/survivorship/long-term-side-effects-cancer-treatment. Accessed 09/2019.

Besser J, Stropahl M, Urry E, Launer S. Comorbidities of hearing loss and the implications of multimorbidity for audiological care. Hear Res. 2018;369:3–14. https://doi.org/10.1016/j.heares.2018.06.008.

Article  Google Scholar 

Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, Hall MD, Amable L, Cunningham LL. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun. 2017;8(1). https://doi.org/10.1038/s41467-017-01837-1.

Carabellese C, Appollonio I, Rozzini R, Bianchetti A, Frisoni GB, Frattola L, Trabucchi M. Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc. 1993;41(4):401–7.

Article  CAS  Google Scholar 

Chia EM, Wang JJ, Rochtchina E, Cumming RR, Newall P, Mitchell P. Hearing impairment and health-related quality of life: the Blue Mountains Hearing Study. Ear Hear. 2007;28(2):187–95 (PM:17496670).

Article  Google Scholar 

Chisolm TH, Johnson CE, Danhauer JL, Portz LJP, Abrams HB, Lesner S, McCarthy PA, Newman CW. A systematic review of health-related quality of life and hearing aids: final report of the American Academy of Audiology Task Force on the health-related quality of life benefits of amplification in adults. J Am Acad Audiol. 2007;18(02):151–83. https://doi.org/10.3766/jaaa.18.2.7.

Article  Google Scholar 

Choi JS, Betz J, Li L, Blake CR, Sung YK, Contrera KJ, Lin FR. Association of using hearing aids or cochlear implants with changes in depressive symptoms in older adults. JAMA Otolaryngol-Head Neck Surg. 2016;142(7):652–7.

Article  Google Scholar 

Cianfrone G, Pentangelo D, Cianfrone F, Mazzei F, Turchetta R, Orlando M, Altissimi G. Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide. Eur Rev Med Pharmacol Sci. 2011;15(6):601–36.

CAS  Google Scholar 

Clark J. Uses and abuses of hearing loss classification. ASHA. 1981;23:493–500.

CAS  Google Scholar 

Cruickshanks K, Klein R, Klein B, et al. Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA. 1998;279(21):1715–9.

Article  CAS  Google Scholar 

Dalton DS, Cruickshanks KJ, Klein BE, Klein R, Wiley TL, Nondahl DM. The impact of hearing loss on quality of life in older adults. Gerontologist. 2003;43(5):661–8 (PM:14570962).

Article  Google Scholar 

Dawes P, Cruickshanks KJ, Fischer ME, Klein BEK, Klein R, Nondahl DM. Hearing-aid use and long-term health outcomes: hearing handicap, mental health, social engagement, cognitive function, physical health, and mortality. Int J Audiol. 2015;54(11):838–44. https://doi.org/10.3109/14992027.2015.1059503.

Article  Google Scholar 

Deal JA, Reed NS, Kravetz AD, Weinreich H, Yeh C, Lin FR, Altan A. Incident hearing loss and comorbidity. JAMA Otolaryngol-Head Neck Surg. 2019;145(1):36. https://doi.org/10.1001/jamaoto.2018.2876.

Article  Google Scholar 

Driscoll C, Beswick R, Doherty E, D’Silva R, Cross A. The validity of family history as a risk factor in pediatric hearing loss. Int J Pediatr Otorhinolaryngol. 2015;79(5):654–9. https://doi.org/10.1016/j.ijporl.2015.02.007.

Article  Google Scholar 

Dutta A, Venkatesh MD, Kashyap RC. Study of the effects of chemotherapy on auditory function. Indian J Otolaryngol Head Neck Surg. 2005;57(3):226–8. https://doi.org/10.1007/BF03008019.

Article  CAS  Google Scholar 

El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, . . . Dolan ME. Clinical and genome-wide analysis of cisplatin-induced tinnitus implicates novel ototoxic mechanisms. Clin Cancer Res. 2019;25(13):4104-4116. https://doi.org/10.1158/1078-0432.ccr-18-3179.

EsfahaniMonfared Z, Khosravi A, SafaviNaini A, Radmand G, Khodadad K. Analysis of cisplatin-induced ototoxicity risk factors in iranian patients with solid tumors: a cohort, prospective and single institute study. Asian Pac J Cancer Prev. 2017;18(3):753–8. https://doi.org/10.22034/APJCP.2017.18.3.753.

Article  Google Scholar 

FDA Center for Drug Evaluation and Research. FDA Label for Sodium Thiosulfate Injection [9/20/2022]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203923Orig1s000Lbl.pdf.

Febles NK, Bauer MA, Ding B, Zhu X, Gallant ND, Frisina RD. A combinatorial approach to protect sensory tissue against cisplatin-induced ototoxicity. Hear Res. 2022;415:108430. https://doi.org/10.1016/j.heares.2022.108430.

Article  Google Scholar 

Fennec Pharmaceuticals. Fennec pharmaceuticals receives fast track designation by FDA for Pedmark Research Triangle Park, NC [March 21, 2018]. Available from: http://fennecpharma.com/fennec-pharmaceuticals-receives-fast-track-designation-by-fda-for-pedmark/.

Food & Drug Administration. Docket No. FDA-2021-N-0862; Nonprescription Drug Product with an Additional Condition for Nonprescription Use. Website: Federal Register: Nonprescription Drug Product With an Additional Condition for Nonprescription Use. (2022; last viewed June 27, 2022).

Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2017;18(1):63–74.

Article  CAS  Google Scholar 

Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol. 2016;34(23):2712–20. https://doi.org/10.1200/jco.2016.66.8822.

Article  CAS  Google Scholar 

Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB. Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy. J Clin Oncol. 2017;35(11):1211–22. https://doi.org/10.1200/jco.2016.70.3108.

Article  CAS  Google Scholar 

Guthrie O, Spankovich C (TBD) Emerging and established therapies for chemotherapy-induced ototoxicity. J Cancer Survivorship

Hanna NH, Einhorn LH. Testicular cancer — discoveries and updates. N Engl J Med. 2014;371(21):2005–16. https://doi.org/10.1056/nejmra1407550.

Article  Google Scholar 

Haugnes HS, Stenklev NC, Brydoy M, Dahl O, Wilsgaard T, Laukli E, Fossa SD. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. Acta Oncol. 2018;57(8):1075–83. https://doi.org/10.1080/0284186X.2018.1433323.

Article  CAS  Google Scholar 

Henry JA, Thielman EJ, Zaugg TL, Kaelin C, Schmidt CJ, Griest S, McMillan GP, Myers P, Rivera I, Baldwin R, Carlson K. Randomized controlled trial in clinical settings to evaluate effectiveness of coping skills education used with progressive tinnitus management. J Speech Lang Hear Res. 2017;60(5):1378–97. https://doi.org/10.1044/2016_JSLHR-H-16-0126.

Holman JA, Drummond A, Naylor G. The effect of hearing loss and hearing device fitting on fatigue in adults: a systematic review. Ear Hear. 2021;42(1):1–11. https://doi.org/10.1097/AUD.0000000000000909.

Article  Google Scholar 

Isherwood B, Gonçalves AC, Cousins R, Holme R. The global hearing therapeutic pipeline:2021. Drug Discov Today. 2021. https://doi.org/10.1016/j.drudis.2021.11.009.

Article  Google Scholar 

Joo Y, Cruickshanks KJ, Klein BEK, Klein R, Hong O, Wallhagen MI. The contribution of ototoxic medications to hearing loss among older adults. J Gerontol: Series A. 2020;75(3):561–6. https://doi.org/10.1093/gerona/glz166.

Article  Google Scholar 

Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB. Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study. J Clin Oncol. 2018;36(15):1505–12. https://doi.org/10.1200/jco.2017.77.0735.

Article  CAS  Google Scholar 

Kitterick PT, Ferguson MA. Hearing aids and health-related quality of life in adults with hearing loss. JAMA. 2018;319(21):2225–6. https://doi.org/10.1001/jama.2018.5567.

Article  Google Scholar 

Knight K, Kraemer D, Neuwelt E. Ototoxicity in children receiving platinum chemotherapy: understanding a commonly occuring toxicity that may influance academic and social development. J Clin Oncol. 2005;23(34):8588–96.

Article  Google Scholar 

Knight K, Kraemer D, Winter C, et al. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol. 2007;25:1190–5.

Article  CAS  Google Scholar 

Kumar A, Gulati R, Singhal S, Hasan A, Khan A. The effect of smoking on the hearing status-a hospital based study. J Clin Diagn Res. 2013;7(2):210–4. https://doi.org/10.7860/jcdr/2013/4968.2730.

Article  Google Scholar 

Landier W. Ototoxicity and cancer therapy. Cancer. 2016;122(11):1647–58. https://doi.org/10.1002/cncr.29779.

Article  Google Scholar 

Landier W, Knight K, Wong FL, Lee J, Thomas O, Kim H, Kreissman SG, Schmidt ML, Chen L, London WB, Gurney JG, Bhatia S. Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales—a report from the Children’s Oncology Group. J Clin Oncol. 2014;32(6):527–34. https://doi.org/10.1200/jco.2013.51.2038.

Article  Google Scholar 

Lee H, Kang D, Yeo S, Kim S. Hearing aid effects and satisfaction in patients with tinnitus. J Clin Med. 2022;11(4):1096. https://doi.org/10.3390/jcm11041096.

Article  Google Scholar 

Lin FR. Hearing loss and cognition among older adults in the United States. J Gerontol A Biol Sci Med Sci. 2011;66A(10):1131–6. https://doi.org/10.1093/gerona/glr115.

Article  Google Scholar 

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, . . . Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413-446. https://doi.org/10.1016/s0140-6736(20)30367-6

Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, . . . Mukadam N. Dementia prevention, intervention, and care. The Lancet. 2017;390(10113):2673–2734. https://doi.org/10.1016/S0140-6736(17)31363-6.

Loughrey DG, Kelly ME, Brennan S, Lawlor BA. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol-Head & Neck Surg. 2018;144(2):115–26. https://doi.org/10.1001/jamaoto.2017.2513.

Article  Google Scholar 

Martin SS, and Cardoso R. BMJ Best Practice: Hypercholesterolemia. BMJ Publishing Group 2022. 2021. Retrieved Aug 8 from https://bestpractice.bmj.com/topics/en-us/170.

Marshak T, Steiner M, Kaminer M, Levy L, Shupak A. Prevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled study. Otolaryngol Head Neck Surg. 2014;150(6):983–90.

Article  Google Scholar 

McMahon CM, Kifley A, Rochtchina E, Newall P, Mitchell P. The contribution of family history to hea